Back to Journals » The Application of Clinical Genetics » Volume 14

Greig Cephalopolysyndactyly (GCPS) Contiguous Gene Syndrome in a Boy with a 14 Mb Deletion in Region 7p13-14 Caused by a Paternal Balanced Insertion (5; 7) [Expression of Concern]

Authors Schulz S, Volleth M, Muschke P, Wieland I, Wieacker P

Received 19 February 2021

Accepted for publication 19 February 2021

Published 5 March 2021 Volume 2021:14 Pages 87—88

DOI https://doi.org/10.2147/TACG.S307411



Schulz S, Volleth M, Muschke P, Wieland I, Wieacker P. Appl Clin Genet. 2008;1:19–22.

The Editor-in-Chief and Publisher of The Application of Clinical Genetics wish to issue an Expression of Concern for the above published article.

The original article contained a clinical image of a child, who was the focus of this case study. It came to our attention that the article does not include a statement to confirm that consent for this image was obtained from the parent or guardian of the patient. We attempted to contact the authors of this article and their affiliated institution to confirm if consent to publish was obtained but despite multiple attempts have received no response. We would like to alert readers of this issue and advise that the image of the subject has been replaced with a grey box until further notice. This decision follows the recommendations of the Committee on Publication Ethics (COPE).

The Editor and Dove Medical Press make every effort to ensure publication ethics are upheld and are committed to supporting the high standards of The Application of Clinical Genetics journal.

Read the original article

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.